HomeCompareWTCZF vs MRK

WTCZF vs MRK: Dividend Comparison 2026

WTCZF yields 11111.11% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 WTCZF wins by $155845322245618304.00M in total portfolio value
10 years
WTCZF
WTCZF
● Live price
11111.11%
Share price
$0.02
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$155845322245618304.00M
Annual income
$153,134,179,268,263,440,000,000.00
Full WTCZF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — WTCZF vs MRK

📍 WTCZF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodWTCZFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, WTCZF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
WTCZF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

WTCZF
Annual income on $10K today (after 15% tax)
$944,444.44/yr
After 10yr DRIP, annual income (after tax)
$130,164,052,378,023,920,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, WTCZF beats the other by $130,164,052,378,023,920,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of WTCZF + MRK for your $10,000?

WTCZF: 50%MRK: 50%
100% MRK50/50100% WTCZF
Portfolio after 10yr
$77922661122809152.00M
Annual income
$76,567,089,634,131,720,000,000.00/yr
Blended yield
98.26%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

WTCZF
No analyst data
Altman Z
-11.4
Piotroski
1/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

WTCZF buys
0
MRK buys
0
No recent congressional trades found for WTCZF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricWTCZFMRK
Forward yield11111.11%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$155845322245618304.00M$56.8K
Annual income after 10y$153,134,179,268,263,440,000,000.00$9,798.13
Total dividends collected$155665220770885760.00M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: WTCZF vs MRK ($10,000, DRIP)

YearWTCZF PortfolioWTCZF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$1,121,811$1,111,111.11$11,206$366.19+$1.11MWTCZF
2$117,691,627$116,491,288.80$12,650$502.35+$117.68MWTCZF
3$11,547,755,012$11,421,824,971.17$14,407$694.19+$11547.74MWTCZF
4$1,059,734,753,299$1,047,378,655,436.53$16,585$967.82+$1059734.74MWTCZF
5$90,963,535,000,723$89,829,618,814,692.62$19,342$1,363.89+$90963534.98MWTCZF
6$7,303,524,681,616,793$7,206,193,699,166,020.00$22,913$1,947.19+$7303524681.59MWTCZF
7$548,553,313,414,587,650$540,738,542,005,257,700.00$27,662$2,823.89+$548553313414.56MWTCZF
8$38,543,778,083,006,005,000$37,956,826,037,652,400,000.00$34,159$4,173.35+$38543778083005.97MWTCZF
9$2,533,778,483,509,246,600,000$2,492,536,640,960,430,300,000.00$43,337$6,308.80+$2533778483509246.50MWTCZF
10$155,845,322,245,618,300,000,000$153,134,179,268,263,440,000,000.00$56,776$9,798.13+$155845322245618304.00MWTCZF

WTCZF vs MRK: Complete Analysis 2026

WTCZFStock

Copper Lake Resources Ltd. engages in the exploration, evaluation, and development of mineral properties in Canada. It explores for copper, zinc, silver, gold, nickel, cobalt, platinum, and palladium mineral properties. The company primarily focuses on the exploration and development of the Marshall Lake property that includes 43 mineral claims with an area of 8,864 hectares, as well as 89 mining leases with an area of 1,566.17 hectares for a total land position of 10,430.17 hectares situated north of Thunder Bay, Ontario; the Norton Lake property that consists of 32 claims covering approximately 8,800 hectares located to the north of Thunder Bay, Ontario; and holds 25% interest in Centrefire Redhat gold-copper property. The company was formerly known as White Tiger Mining Corp. and changed its name to Copper Lake Resources Ltd. in September 2014. Copper Lake Resources Ltd. was incorporated in 1984 and is headquartered in Toronto, Canada.

Full WTCZF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this WTCZF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

WTCZF vs SCHDWTCZF vs JEPIWTCZF vs OWTCZF vs KOWTCZF vs MAINWTCZF vs JNJWTCZF vs ABBVWTCZF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.